Table 3. Findings on the Association Between Vision Impairment or Eye Disease and Quality of Life by Systematic Reviewa.
Systematic reviewa | Year | Country of lead author | Quality of life outcome or measure | Assessment instruments | Participants, No.b | Participant type | Studies, No. | Study type | Countries of primary studiesb | Results/findings |
---|---|---|---|---|---|---|---|---|---|---|
Systematic reviews of quantitative studies | ||||||||||
Nyman, et al47 | 2010 | UK | Mental health subscale in QOL questionnaires | NEI-VFQ-25 and SF-36 | 33 648 | Working-age adults (18-59 y) | 11 | NR | The US, Korea, and India | Vision impairment was associated with modestly lower mental health scores on the NEI-VFQ-25 than control participants (average mean difference, 14.5% [range, 0.6%-35%]). The SF-36 was less sensitive than the NEI-VFQ-25 in detecting lower mental health among those with vision impairment vs controls (mean difference, 3%; 1 study only). |
Nyman, et al47 | 2010 | UK | QOL | NR | 2622 | Working-age adults (18-59 y) | 3 | NR | The US, Sweden, and Australia | Vision impairment was associated with lower QOL across a range of measures, such as higher odds of reporting “not feeling full of life” vs control participants (OR, 4.63 [95% CI, 2.1-9.8]) |
Tseng, et al49 | 2018 | Taiwan | QOL | WHOQOL-BREF, CDCHRQOL, SF-36, IVI, NHVQOL, EQ-5D, NEI-VFQ-25, and WHO/PBD VF20 | NR | Older adults | 15 | 14 cross-sectional and 1 longitudinal study | Australia, Canada, Europe, Germany, Korea, Nepal, New Zealand, Nigeria, Philippines, Taiwan, and the US | Vision impairment was associated with lower QOL in 14 of 15 studies (eg, OR, 2.20 [95% CI, 1.10-4.90] in 1 study examining vision impairment and generic health-related QOL; in another study examining vision impairment among older adults, the difference in SF-36 scores was 6.7 (95% CI, 3.37-10.1; P < .001). An increase in vision impairment severity was associated with lower QOL (eg, β, 0.31 [95% CI, 0.11-0.52]; P = .003). |
Schakel, et al48 | 2019 | The Netherlands | Fatigue severity | SF-36 vitality subscale or Fatigue Assessment Scale | 10 870 | Adults | 14 | 7 case-control and 7 cross-sectional studies | Australia, Brazil, China, Greece, Japan, Nepal, the Netherlands, Taiwan, and the US | Vision impairment was associated with higher levels of fatigue in affected participants vs control participants with normal sight (standardized mean difference [SMD], −0.36 [95% CI, −0.50 to −0.22]; I2 = 84%). |
Schakel, et al48 | 2019 | The Netherlands | Fatigue odds | SF-36 vitality subscale or Fatigue Assessment Scale | 8053 | Adults | 4 | 2 cross-sectional and 2 case-control studies | Canada, Czech Republic, Germany, and the Netherlands | Vision impairment was associated with higher odds of fatigue in affected participants vs control participants with normally sight (pooled adjusted OR, 2.61 [95% CI, 1.69-4.04]; I2 = 90%). |
Wang, et al50 | 2017 | China | Disease-specific QOL | GQL-15 questionnaire | 253 | Individuals with glaucoma | 2 | NR | Australia and Nigeria | Glaucoma was associated with significantly higher (ie, poorer) QOL summary scores (SMD , 0.94 [95% CI, 0.73-1.16]; P < .001; I2 = 0%), and subscale scores for all 4 factors (central and near vision: SMD, 0.82 (95% CI, 0.61-1.04]; P < .001; peripheral vision: SMD, 0.74 [95% CI, 0.53-0.96]; P < .001; dark adaption and glare: SMD, 1.02 [95% CI, 0.80-1.24]; P < .001; outdoor mobility: SMD, 0.60 [95% CI, 0.39-0.81]; P < .001) vs control group without glaucoma. |
Khoo, et al6 | 2019 | Singapore | Psychosocial functioning | Depression or anxiety questionnaires and mental health QOL subscale scores | NR | Individuals with diabetic retinopathy | 28 | Cross-sectional | NR | Diabetic retinopathy was significantly associated with poor psychosocial functioning in 20 of 28 observational studies (measures of association not provided). |
D’Amanda, et al53 | 2020 | US | QOL | NEI-VFQ-25, VF-14, SF-12, HRQOL-14, WHOQOL-BREF, CHQ, SF-36, and PedsQL | 905 | Individuals with mendelian eye conditions | 11 | Cross-sectional | Brazil, Canada, France, Greece, Israel, Korea, the Netherlands, and the UK | Retinitis pigmentosa, Usher syndrome, mixed retinal dystrophies, and retinoblastoma (in children) were associated with lower overall QOL in 5 studies. CHARGE syndrome, albinism, retinoblastoma, and mixed retinal dystrophies were associated with lower QOL on certain subscales (not specified) in 6 studies (measures of association not provided). |
Systematic reviews of qualitative studies | ||||||||||
Nyman, et al7 | 2012 | UK | Emotional well-being | NA | NR | Older adults | NR | Qualitative | NR | Diagnosis of vision impairment was identified as a traumatic event in 8 studies. An array of emotions was reported around the time of diagnosis, including feelings of shock, fear, panic, distress, helplessness, and frustration. |
Nyman, et al7 | 2012 | UK | General functioning | NA | NR | Older adults | NR | Qualitative | NR | Vision impairment had a dramatic outcome on individuals’ daily lives and functioning. People reported having to relinquish independence (11 studies) and leisure pursuits (8 studies). |
Bennion, et al51 | 2012 | UK | Emotional well-being | NA | 121 | Individuals with age-related macular degeneration | 5 | Qualitative | NR | The diagnosis of age-related macular degeneration was described as a shocking even by participants. Some accepted the diagnosis, while others felt powerless and in despair. Negative thoughts and depression symptoms were not confined to those with the most severe cases. |
D’Amanda, et al53c | 2020 | US | General and visual functioning | NA | 430 | Individuals with mendelian eye conditions | 9c | Qualitative | Australia, the Netherlands, Ireland, Sweden, Tanzania, the UK, the US, and Zimbabwe | Vision impairment had a considerable association with visual and global daily functioning and specific aspects of life, such as education, employment, and relationships among people with mendelian eye conditions (albinism, mixed retinal dystrophies, Leber hereditary optic neuropathy, retinitis pigmentosa, Alstrom syndrome, and retinoblastoma). |
Garip, et al52 | 2019 | UK | Emotional well-being | NA | 223 | Individuals with retinitis pigmentosa | 10c | Qualitative | Australia, the US, Republic of Korea, Ireland, the Netherlands, and the UK | The diagnosis of retinitis pigmentosa was commonly accompanied by shock, negative emotional states, and a loss of confidence. Participants reported fatigue, fear, isolation, and vulnerability as they coped with the disease and dealt with their own judgements and perceived stigma. |
Garip, et al52 | 2019 | UK | Visual functioning | NA | 223 | Individuals with retinitis pigmentosa | 10c | Qualitative | Australia, the US, Republic of Korea, Ireland, the Netherlands, and the UK | The diagnosis of retinitis pigmentosa was accompanied by loss of visual acuity, hobbies, pastimes, and social support. Participants reported difficulty performing day-to-day tasks, such as reading, seeing in changing light conditions, shopping, driving, playing sports, taking part in leisure activities, and doing household chores. |
Abbreviations: CDCHRQOL, Centers for Disease Control and Prevention Health-Related Quality of Life; CHARGE syndrome, coloboma, heart defects, atresia choanae, growth retardation, genital abnormalities, and ear abnormalities; CHQ, Children’s Health Questionnaire; EQ-5D, EuroQoL–5 Dimension; GQL-15 questionnaire, Glaucoma Quality of Life–15 questionnaire; HRQOL-14, Health-Related Quality of Life–14; IVI, impact of vision impairment; NA, not applicable; NEI-VFQ-25, National Eye Institute 25-Item Visual Function Questionnaire; NHVQoL, Nursing Home Vision-Targeted Health-Related Quality of Life; NR, not reported; OR, odds ratio; PedsQL, Pediatric Quality of Life Inventory; QOL, quality of life; SF-12, 12-Item Short Form Survey; SF-36, 36-Item Short Form Health Survey; VF-14, Visual Function Index; WHOQOL-BREF, World Health Organization Quality of Life BREF; WHO/PBD VF20, World Health Organization Prevention of Blindness and Deafness Visual Function–20.
Quality of evidence ratings were not reported for any study.
Informing the specific outcome (a given systematic review may have included more studies for other outcomes).
Two identical primary studies were included in both reviews.